Your browser doesn't support javascript.
loading
Genetics of personalized medicine: cancer and rare diseases.
Alves, Inês Teles Siefers; Condinho, Manuel; Custódio, Sónia; Pereira, Bruna F; Fernandes, Rafael; Gonçalves, Vânia; da Costa, Paulo J; Lacerda, Rafaela; Marques, Ana Rita; Martins-Dias, Patrícia; Nogueira, Gonçalo R; Neves, Ana Rita; Pinho, Patrícia; Rodrigues, Raquel; Rolo, Eva; Silva, Joana; Travessa, André; Leite, Rosário Pinto; Sousa, Ana; Romão, Luísa.
Afiliación
  • Alves ITS; Department of Cell Biology and Biochemistry, Springer Science + Business Media B.V, Van Godewijckstraat 30, 3311, GX, Dordrecht, The Netherlands. ines.alves@springernature.com.
  • Condinho M; Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
  • Custódio S; Biosystems & Integrative Sciences Institute (BioISI), Faculty of Sciences, University of Lisbon, Lisbon, Portugal.
  • Pereira BF; Medical Genetics Service, Pediatric Department, Hospital Santa Maria, Lisbon, Portugal.
  • Fernandes R; Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
  • Gonçalves V; Biosystems & Integrative Sciences Institute (BioISI), Faculty of Sciences, University of Lisbon, Lisbon, Portugal.
  • da Costa PJ; Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
  • Lacerda R; Biosystems & Integrative Sciences Institute (BioISI), Faculty of Sciences, University of Lisbon, Lisbon, Portugal.
  • Marques AR; Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
  • Martins-Dias P; Biosystems & Integrative Sciences Institute (BioISI), Faculty of Sciences, University of Lisbon, Lisbon, Portugal.
  • Nogueira GR; Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
  • Neves AR; Biosystems & Integrative Sciences Institute (BioISI), Faculty of Sciences, University of Lisbon, Lisbon, Portugal.
  • Pinho P; Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
  • Rodrigues R; Biosystems & Integrative Sciences Institute (BioISI), Faculty of Sciences, University of Lisbon, Lisbon, Portugal.
  • Rolo E; Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
  • Silva J; Biosystems & Integrative Sciences Institute (BioISI), Faculty of Sciences, University of Lisbon, Lisbon, Portugal.
  • Travessa A; Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
  • Leite RP; Biosystems & Integrative Sciences Institute (BioISI), Faculty of Sciences, University of Lisbon, Lisbon, Portugal.
  • Sousa A; Department of Human Genetics, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
  • Romão L; Biosystems & Integrative Sciences Institute (BioISI), Faculty of Sciences, University of Lisbon, Lisbon, Portugal.
Cell Oncol (Dordr) ; 41(3): 335-341, 2018 Jun.
Article en En | MEDLINE | ID: mdl-29633150
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Raras / Medicina de Precisión / Neoplasias Tipo de estudio: Prognostic_studies Aspecto: Ethics Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Cell Oncol (Dordr) Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Raras / Medicina de Precisión / Neoplasias Tipo de estudio: Prognostic_studies Aspecto: Ethics Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Cell Oncol (Dordr) Año: 2018 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Países Bajos